锡尔图因
白藜芦醇
西妥因1
热卡限制
SIRT3
神经保护
药理学
NAD+激酶
激活剂(遗传学)
烟酰胺腺嘌呤二核苷酸
生物利用度
生物
辅活化剂
化学
受体
内分泌学
生物化学
转录因子
下调和上调
酶
基因
作者
Francisco J. Alcaı́n,José M. Villalba
标识
DOI:10.1517/13543770902762893
摘要
Background: Sirtuin 1 – 7 (SIRT1 – 7) are deacetylases that are dependent on NAD+ for their activity. SIRT1 down-regulates p53 activity, increasing lifespan, cell survival, and neuroprotection; it also deacetylates peroxisome proliferator-activated receptor-γ and its coactivator 1α, promoting fat mobilization, increasing mitochondrial size and number, and positively regulating insulin secretion. Sirtuins link nutrient availability and energy metabolism. Calorie restriction, which increases lifespan and is beneficial in age-related disorders, activates sirtuin. Major efforts are thus focused to developing sirtuin activators. Objective: After discussing the potential involvement of sirtuins in pathophysiological processes, this review looks at new, synthetic sirtuin activators. Conclusions: To date, resveratrol is the most potent natural compound able to activate SIRT1, mimicking the positive effect of calorie restriction. Resveratrol might help in the treatment or prevention of obesity and in preventing the aging-related decline in heart function and neuronal loss. As resveratrol has low bioavailability and interacts with multiple molecular targets, the development of new molecules with better bioavailability and targeting sirtuin at lower concentrations is a promising field of the medicinal chemistry. New SIRT1 activators that are up to 1000 times more effective than resveratrol have recently been identified. These improve the response to insulin and increase the number and activity of mitochondria in obese mice. Human trials with a formulation of resveratrol with improved bioavailability and with a synthetic SIRT1 activator are in progress.
科研通智能强力驱动
Strongly Powered by AbleSci AI